FDA rejects Akebia drug, dealing another blow to anemia pills

The Food and Drug Administration rejected an Akebia Therapeutics' anemia pill vadadustat, the company announced Wednesday, over concerns the drug isn't as safe as currently approved injectable medicines for patients with chronic kidney disease.